Antibiotice

Eurofins Scientific is an international life sciences company, providing a unique range of analytical testing services to clients across multiple industries, to make life and the environment safer, healthier and more sustainable. From the food you eat to the medicines you rely on, Eurofins works with the biggest companies in the world to ensure the products they supply are safe, their ingredients are authentic and labelling is accurate. Eurofins is a global leader in food, environmental, pharmaceutical and cosmetic product testing and in agroscience CRO services. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies.

In over just 30 years, Eurofins has grown from one laboratory in Nantes, France to over 50,000 staff across a network of more than 900 independent companies in over 50 countries, operating more than 800 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.

Eurofins is one of the fastest growing listed European companies. Since its IPO on the French stock exchange in 1997, Eurofins’ sales have increased by 35% each year (in compound average) to over EUR 4.5 billion in 2019.

Dokumeds is your guide through the clinical development journey towards the market, in Europe and beyond: transparent budgets, cost-effective solutions and accelerated timelines.

Taros Chemicals GmbH & Co. KG, an independent, privately owned contract research organization based in Dortmund, Germany, has been serving the chemistry needs of pharmaceutical, chemical and biotech companies since its inception in 1999. A forerunner in the early German biotech scene, Taros can claim more than 13,000 syntheses, research and process chemistry projects delivered to-date to an increasingly expanding and diverse base of global customers.

In its state-of-the-art facilities in Dortmund's prestigious BioMedizinZentrum (BMZ), the hub of top ranking biotech organizations, Taros'​ team of highly creative and skilled scientists, aided by its state-of-the-art laboratory facilities, are wholly committed to solving a wide range of customers'​ R&D problems in innovative drug discovery, medicinal chemistry and classical synthetic chemistry. Their collective knowledge and experience in industrial organic chemistry, span a period of over 160 years, and in active drug discovery, around 60 years, covering the full spectrum, from big pharma to biotechnology. Taros is active today in therapeutic areas which include oncology, respiratory, CNS, cardiovascular, inflammation, pain, metabolism and infectious diseases, in all small-molecule target classes.

Our company's mission is to enhance the quality of human lives by providing advanced and innovative chemistry-driven technologies to our customers R&D endeavors in the global marketplace. We strive hard to provide creative, holistic and cost-effective solutions with the highest level of quality, reliability and integrity. We continuously endorse loyalty and commitment in our employees, inspiring them to provide exceptional value to our customers'​ R&D processes, by anticipating hurdles before they arise, by foreseeing potential cost and lead time reductions, and most importantly, by facilitating their competitive and "early to market"​ advantage.

Joint Stock Company Grindeks is an international, vertically integrated pharmaceutical company in the Baltic States, Latvia. The main fields of action are research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients.
The main therapeutic groups of Grindeks are cardiovascular, central nervous system, anti-cancer and diabetes medicines.

Current vacancies in Latvia: http://www.grindeks.lv/lv/karjera/grindeks-darba-piedavajumi

HENNIG Arzneimittel is a mid-sized family-owned German pharmaceutical company based near Frankfurt with 120 years of grown experience. Its success is based upon four main pillars :

HENNIG Arzneimittel offers proprietary drugs to the German market in the indication vertigo and disturbances of equilibrium where it is market leader.

Besides this HENNIG Arzneimittel manufactures and offers a broad range of generics - among these all generically available antivertigo products. Further core areas regard cardiovascular, metabolism, pain, neurologic and psychiatric products.

A rapidly growing range of over-the-counter drugs, devices and food supplements is complementing HENNIG's product portfolio, strengthening its consumer orientation.

The fourth pillar is contract manufacturing and contract development services, both for pharmaceuticals and food supplements, with a special focus upon complex solid dosage forms for modified release. Technologies include tableting, coating, dry and wet granulation, extrusion, pelletising, dry-coated tablets and capsule filling, as well as blistering and secondary packaging. The equipment allows easy scale-up from lab scale to industrial scale. HENNIG Arzneimittel offers customer-specific services, ranging from feasability studies up to full service.

HENNIG's Team is composed of about 320 employees, among them are about 90 sales reps.